StonvexLoading…
StonvexStonvexStonvexCore line items from KALU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.37B | $3.02B | $3.09B | $3.43B |
Operating Income | $188.80M | $112.20M | $122.50M | $4.00M |
Net Income | $112.50M | $65.70M | $67.80M | $-29.60M |
EPS (Diluted) | $6.77 | $4.02 | $4.21 | $-1.86 |
Total Assets | $2.56B | $2.41B | $2.27B | $2.29B |
Total Liabilities | $1.74B | $1.67B | $1.62B | $1.66B |
Cash & Equivalents | $7.00M | $18.40M | $82.40M | $57.40M |
Free Cash Flow OCF − CapEx | $-25.50M | $-13.70M | $68.70M | $-205.60M |
Shares Outstanding | 16.21M | 16.10M | 16.02M | 15.94M |